Xiaoqi Li

Xiaoqi Li

Auto-generated profile, based on publicly available information

Xiaoqi Li

Medical School of Chinese PLA, Beijing, China; State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
XHXiaotian Han
Xiaotian Han
YLYe-Chen Lu
Ye-Chen Lu
XLXiaoqi Li
Xiaoqi Li
LXLingfang Xia
Lingfang Xia
HWHao Wen
Hao Wen
XWXiaohua Wu
Xiaohua Wu
Background: Epithelial ovarian cancer (EOC) is the main subtype of ovarian cancer and shows an aggressive phenotype and poor prognosis. Neuronal pentraxin II (NPTX2) is a member of the neuronal pentraxin family and plays a contradictory role in different tumors. However, there has been no report about the possible role and effect of NPTX2 in EOC.Methods: Bioinformatics analysis, qPCR, western blotting and immunohistochemistry were used to detect the expression of NPTX2 in EOC. Lentivirus-based transfection for NPTX2 overexpression or knockdown was performed on the EOC cell lines A2780, HEY, SKOV3 and OVCAR-3. The effect of NPTX2 on the malignant phenotype of EOC was examined through methods of MTS assay, Edu assay, transwell assay, western blotting analysis, qPCR analysis, luciferase reporter assay and xenograft experiment.Results: EOC tissues showed higher NPTX2 expression than the normal tissues with poor prognosis. NPTX2 overexpression can promote the proliferation, invasion, migration and tumorigenesis of EOC via IL6-JAK2/STAT3 signaling pathway. Moreover, hypoxia-inducible factor-1(HIF-1) can promote the transcription and expression of NPTX2 under the hypoxic environment. NPTX2 knockdown abolished the hypoxia-induced malignant phenotypes in ECO.Conclusions: The above results suggest that NPTX2 may play a novel role in ovarian cancer’s malignant phenotype and act as a promising treatment target for EOC molecular therapy.

28 July 2023 in The American Journal of Pathology
Verified
Journal Article
Closed access
XLXiaoqi Li
Xiaoqi Li
YQYingxin Qu
Yingxin Qu
QYQinghua Yang
Qinghua Yang
RLRunpu Li
Runpu Li
YDYumei Diao
Yumei Diao
YHYifei Huang
Yifei Huang